Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tailoring antihypertensive therapy in 1991.

D G Vidt1

  • 1Department of Hypertension and Nephrology, Cleveland Clinic Foundation, Ohio 44195.

Cleveland Clinic Journal of Medicine
|May 1, 1991
PubMed
Summary

Personalized hypertension treatment will focus on non-drug approaches for mild cases. Future antihypertensive drug selection will prioritize long-term outcomes and quality of life over rigid guidelines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenesis and treatment of resistant hypertension.

Minerva medica·2003
Same author

Ischaemic nephropathy: can we preserve renal function?

Journal of human hypertension·2002
Same author

New strategies for blood pressure control.

Journal of human hypertension·2002
Same author

Clinical trials report. The effect of Ramipril versus Amlodipine on renal outcomes in hypertension nephrosclerosis.

Current hypertension reports·2001
Same author

Current treatment of hypertension.

Minerva medica·2001
Same author

A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II.

Journal of human hypertension·2001

Area of Science:

  • Cardiology
  • Pharmacology
  • Internal Medicine

Background:

  • Hypertension management is evolving towards individualized patient care.
  • Non-pharmacologic interventions are crucial for initial management of mild hypertension.
  • The growing number of antihypertensive medications necessitates personalized treatment strategies.

Purpose of the Study:

  • To outline the future direction of hypertension treatment in the 1990s.
  • To emphasize the shift from stepped-care guidelines to tailored therapeutic approaches.
  • To highlight the importance of considering long-term effects and quality of life in drug selection.

Main Methods:

  • Review of current trends in hypertension management.
  • Analysis of the expanding pharmacopeia of antihypertensive agents.
  • Discussion of patient-specific factors influencing treatment choices.

Main Results:

  • Non-pharmacologic methods are recommended as the first line of treatment for mild hypertension.
  • Clinicians will increasingly select antihypertensive drugs based on individual patient profiles.
  • Treatment decisions will move beyond basic safety and efficacy to include long-term impact and quality of life.

Conclusions:

  • Tailored care will become the standard for hypertension management.
  • Antihypertensive drug selection will be highly individualized.
  • Long-term patient well-being and quality of life will guide therapeutic choices.

Related Experiment Videos